# Ganesh Benzoplast share price today (Ganesh Benzoplast Ltd, NSE: GANESHBE)

> Ganesh Benzoplast share price today: ₹94.80 at the NSE close on 3 November 2026, up 9.7% in a year. Ganesh Benzoplast (NSE: GANESHBE) is worth ₹682 crore, trades at a P/E of 10.4 and has closed between ₹69.86 and ₹138.30 over the past 52 weeks. > Ganesh Benzoplast Ltd's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. GANESHBE · Chemicals - Inorganic · data as of 3 November 2026. Page: https://www.sectoralpha.in/stocks/ganesh-benzoplast-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Turning around, from the last 12 quarters
- Price: ₹94.80 (+9.7% in a year)
- P/E: 10.4× (lower than 58% of the last 7.4 years)
- Revenue (Jun 2026): ₹118 Cr (+22.9% on a year ago)
- Profit (Jun 2026): ₹18.0 Cr (+0.0% on a year ago)
- Operating margin: 23.0% (−7.0 points on a year ago)
- ROCE: 15%, FY26
- ROIC: 8.3%, against a 12.0% cost of capital: −3.7 points

The main question: yearly earnings per share moved +94.0% while the share price moved +9.7%. ## What is the Ganesh Benzoplast share price today? Ganesh Benzoplast Ltd's share price was ₹94.80 at the close on 3 November 2026. It has been rising for 23 weeks. That is 9.0% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹70 and ₹138, and at that close it sat 36% of the way up from that low. Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 4 weeks running. Over the last 11 years the share price moved +360% while the NIFTY 500 moved +243%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 9 October 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Ganesh Benzoplast this quarter? 2. Revenue up on a year earlier for 5 quarters in a row In the June 2026 quarter revenue was ₹118 crore, +22.9% on a year earlier. 3. Operating margin down 7 points on a year earlier 23% in the June 2026 quarter, from 30%. ## What are Ganesh Benzoplast's latest quarterly results? For April to June 2026 (the quarter ended 30 June 2026), Ganesh Benzoplast reported revenue of ₹118 crore, up 22.9% from ₹96.0 crore a year earlier, and a profit of ₹18.0 crore, up 0.0% from ₹18.0 crore. ### Ganesh Benzoplast results: April to June 2026 against a year earlier

| Measure | April to June 2026 | April to June 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹118 crore | ₹96.0 crore | +22.9% |
| Profit | ₹18.0 crore | ₹18.0 crore | 0.0% |
| Earnings per share | ₹2.44 | ₹2.52 | −3.2% |
| Operating margin | 23.0% | 30.0% | −7.0 points |

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). The newest call in our records is from 7 October 2026, about July to September 2026; a call about these results is not in our records yet. (From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.)

## What is the Ganesh Benzoplast share price history? Ganesh Benzoplast closed at ₹94.80 on 3 November 2026, up 9.7% from ₹86.39 a year earlier (31 October 2025) and up 10.0% over five years. Its highest weekly close since April 2016 was ₹196.15 on 9 February 2024. ### Ganesh Benzoplast share price: then and now

| When | Close | Change to 3 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 23 Oct 2026 | ₹86.60 | +9.5% |
| 1 month ago · 1 Oct 2026 | ₹123.80 | −23.4% |
| 6 months ago · 30 Apr 2026 | ₹99.91 | −5.1% |
| 1 year ago · 31 Oct 2025 | ₹86.39 | +9.7% |
| 3 years ago · 3 Nov 2023 | ₹140.60 | −32.6% |
| 5 years ago · 4 Nov 2021 | ₹86.20 | +10.0% |
| 10 years ago · 4 Nov 2016 | ₹41.70 | +127.3% |
| Earliest weekly close in our records · 1 Apr 2016 | ₹20.60 | +360.2% |
| Highest weekly close since April 2016 · 9 Feb 2024 | ₹196.15 | −51.7% |
| Lowest weekly close since April 2016 · 6 May 2016 | ₹19.95 | +375.2% |
| 52-week high (weekly close) · 28 Sep 2026 | ₹138.30 | −31.5% |
| 52-week low (weekly close) · 1 Feb 2026 | ₹69.86 | +35.7% |

Weekly closing prices. Each change is the move from that price to the 3 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (560 weekly closes from 1 April 2016 to 3 November 2026.)

## What is the latest news on Ganesh Benzoplast? 3 Nov 2026: Ganesh Benzoplast closed at ₹94.80, up 9.5% on the week and down 23.4% on the month. 7 Oct 2026: Ganesh Benzoplast held its results call for July to September 2026. Management guided: Total LST and rail consideration ₹1,154 crore: approximately ₹500 crore by January 2027, ₹300 crore before March 2027, and ₹354 crore over the following 12-18 months. ### Earlier

- Results for April to June 2026: Revenue up 22.9% and profit up 0.0% on a year earlier. ## What dividend does Ganesh Benzoplast pay? Ganesh Benzoplast has paid no dividend on the NSE since 1 April 2021, the start of the period we checked. No. Ganesh Benzoplast Ltd paid out 0% of its profit as dividends in each of its last 13 reported years, so there is no payout history to show. That comes from the filed annual statements, not an estimate. (From the NSE corporate-actions record, read 4 November 2026.)

## What did Ganesh Benzoplast management say on the latest results call? On the call for July to September 2026, held on 7 October 2026, Ganesh Benzoplast's management guided: Total LST and rail consideration ₹1,154 crore: approximately ₹500 crore by January 2027, ₹300 crore before March 2027, and ₹354 crore over the following 12-18 months. > “The only rationale is that we see significant growth potential in EPC and chemicals over the next few years. In terms of growth rates, we believe they could be much higher than those of JNPT or any other liquid terminal business. That is our belief at present.”
> Rishi Pilani, Chairman and Managing Director, on the call for July to September 2026

### What management guided

- Initial tranche: ₹190-200 crore for taxes and bank-limit closure, ₹200 crore for buyback plus special dividend, ₹100 crore for chemical/EPC expansion; no significant bank debt expected. - Chemical revenue around ₹180 crore, hoped to cross ₹200 crore this year; profit above ₹20 crore this year and ₹60-70 crore in 4-5 years; post-expansion growth +20-25%, then +70-80%. - REACH-certified plant expansion planned for July 2027, export orders expected toward 2,000 tons annually; stage-one chemical/EPC capital spending capped at ₹150 crore. - Group profit goal: +15-20% on a year earlier by FY28 from the current ₹70 crore level; combined chemical/EPC profit approximately ₹210 crore in 3-5 years. Management’s own plans and goals, from our notes of the call. A plan is not a result. Source: [the call transcript](https://files.tijorifinance.com/insight/india/109/Conference Call/CC-Oct26.pdf). (From the call for July to September 2026, 7 October 2026.)

## What to watch in Ganesh Benzoplast's next results? When Ganesh Benzoplast reports July to September 2026, these are the 4 checks that show whether the story is still on course. First: Port approvals and shareholder vote - check completion against the first-tranche timing. - What to check (from the call)
- Port approvals and shareholder vote - check completion against the first-tranche timing. - Chemical expansion execution - check capital spending deployment, customer order conversion, and progress toward the stated commissioning date. - EPC execution - check revenue recognition from the KKR-linked project and other contracts against the stated annual ramp. - Capital return - check buyback and special-dividend announcement once proceeds visibility becomes definite, with promoter non-participation confirmed. ## Which stock lists is Ganesh Benzoplast on? Ganesh Benzoplast is on one of our India lists: Penny stocks. [Penny stocks Earnings growth, 12 months (%): 82.64](https://www.sectoralpha.in/penny-stocks-india)

## Is Ganesh Benzoplast profitable? Ganesh Benzoplast Ltd earned ₹18.0 Cr of net profit in the Jun 2026 quarter, +0.0% on the same quarter a year earlier. Full-year FY26 profit was ₹73.0 Cr. Over 10 years profit has grown 4.3% a year on average. That is 15.3% of the quarter's revenue. The same quarter a year earlier earned ₹18.0 Cr. 1 of the last 12 reported quarters were loss-making. For the full year, FY26 profit was ₹73.0 Cr (+92.1% on the year before). Why profit moved: revenue changed +22.9% on a year earlier and the margin moved −7.0 percentage points. Sales did the work while the margin got thinner. On average over the last four quarters, profit changed +13.0% and revenue +13.2%. Profit and revenue are moving at about the same pace. ## How much revenue does Ganesh Benzoplast make, and is it growing? Ganesh Benzoplast Ltd reported ₹118 Cr of revenue in the Jun 2026 quarter, +22.9% on the same quarter a year earlier. That is the 5th quarter in a row with growth on the year before. Over 10 years it has grown 13.2% a year on average. The last full year, FY26, came in at ₹411 Cr. The last four reported quarters add to ₹433 Cr. FY26 revenue was ₹411 Cr, +9.9% on the year before. Recent pace: the last four quarters grew +13.2% on average, against 13.2% a year over the longer run, so this year is growing at about the same pace as its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +13.1%, against −1.1% a year over the last 8 quarters (accelerating); profit over the last 12 months grew +87.2%, against +8.5% a year (accelerating). ## How much of every ₹100 of sales does Ganesh Benzoplast keep? Ganesh Benzoplast Ltd's operating margin was 23.0% in the Jun 2026 quarter, 7.0 percentage points lower than the same quarter a year ago. Across 13 years it has been between 17.0% and 32.0%. The latest quarter is within that range. Why the margin moved: operating margin changed −7.5 percentage points on the year while gross margin changed −5.1 points. So the drop came mostly from the gross margin, which means input costs and prices charged. ## Is Ganesh Benzoplast's profit turning into cash? Over the last 3 years, 120% of Ganesh Benzoplast Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹63.0 Cr of operating cash against ₹73.0 Cr of profit. After ₹69.0 Cr of spending on assets, free cash was −₹6.0 Cr: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 120% of profit came in as cash: the cash cycle got 158 days longer between FY21 and FY26, so more of each rupee of profit waits in the business before it arrives. What to look at next: the bigger use of cash is spending on new assets, at 2.8× depreciation over three years. The next section checks what that spending is building. ## Where does Ganesh Benzoplast's cash go? Ganesh Benzoplast Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 36 days in FY26, up from −122 days in FY21. It spent ₹187 Cr on assets over the last 3 years. Customers take 49 days to pay, and stock sits for 129 days on average. At FY26 sales of ₹411 Cr, each day of that cycle ties up about ₹1.1 Cr, so roughly ₹41.0 Cr is tied up in the business at any time. FY26: customers took 49 days to pay and stock sat for 129 days, about 4.2 months of sales sitting as stock, for a full cycle of 36 days, longer than FY21's −122. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 129 days. Customers pay about 49 days after that. Suppliers are paid at 142 days. Together that makes the 36-day cycle. Spending on assets: ₹187 Cr over the last 3 years, against ₹66.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹21.0 Cr (FY26): assets paid for that are not earning yet. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Ganesh Benzoplast's P/E ratio, and how does it compare with its own history? Ganesh Benzoplast Ltd's P/E is 10.4×, in the middle of its own history: higher than 42% of past readings. Its usual P/E (the middle reading) is 13.5×, over 7.4 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. The P/E here, and its history, use a profit figure that can leave out one-off items, so it can differ from a P/E worked out on the quarterly results. Those results' earnings per share for the four quarters to Jun 2026 add up to ₹10.10. Why the multiple is where it is: over the past year earnings per share moved +94.0% while the price moved +9.7%. Earnings did better than the price, which pulled the multiple down within its own range. Where the price move came from: over 5 years the price moved +1.9% a year; about +25.7% a year came from earnings growth and about −23.8 percentage points from the multiple (the market paying less). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is about average against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Ganesh Benzoplast business getting better or worse? Ganesh Benzoplast Ltd's business is turning around. Profit growth has swung from −37.1% at its low to +87.2%, rising from a low 4 quarters ago, with ROCE rising at 15.4%. This is based on 12 quarters of 4 measures. Why it matters: a turn in growth is often where a bigger change starts. The lines say a turn is forming, so the question is whether the next quarters confirm it. ## How much does Ganesh Benzoplast earn on its capital? Ganesh Benzoplast Ltd earned a ROCE of 15% in FY26. That is up from a low of 2% in FY15. Its return on capital used (ROIC) is 3.7 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 17.8% net margin and 0.48× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 17.8% net margin × 0.48× asset turnover × 1.39× leverage (assets divided by equity) ≈ 11.9% on equity. The margin does most of the work; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: 8.3% − 12.0% = −3.7 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. The 8.3% ROIC above is the latest reading, as reported. The yearly chart below shows FY26 at 9.8%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Ganesh Benzoplast have too much debt? Ganesh Benzoplast Ltd has total debt of ₹76.0 Cr against shareholder equity of ₹618 Cr as of Jun 2026, so its debt is 0.12× its equity, which is very little. Year by year, that ratio went from 0.09 in FY22 to 0.12 in FY26. So the returns on this page come from the business, not from borrowed money. ## What is the Ganesh Benzoplast shareholding pattern? Foreign institutions cut their stake in Ganesh Benzoplast Ltd by 4.6 percentage points over 8 quarters, the biggest change among its owners. Foreign institutions now own 0.5% of the company. Domestic institutions moved +1.6 points over the same period, to 1.6%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Foreign institutions: −4.6 points over 8 quarters, to 0.5%; Domestic institutions: +1.6 points over 8 quarters, to 1.6%; Promoters: +0.0 points over 8 quarters, to 39.0%. Why the owners changed: foreign institutions moved −4.6 points and domestic institutions +1.6 points over 8 quarters, while promoters stayed about the same. One group of institutions took over shares from the other; it is not a change of mind by the people running the company. ## How far is Ganesh Benzoplast from balance-sheet trouble? For Ganesh Benzoplast Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Ganesh Benzoplast rank in its industry? 57.1 out of 100, rank 3 of 9 in Chemicals - Inorganic, with 74% of the evidence available. Ganesh Benzoplast Ltd scores 57.1 out of 100 against the 9 companies it is compared with in Chemicals - Inorganic, ranking 3. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 21.1 + 11.2 + 16.1 + 8.7 = 57.1. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Ganesh Benzoplast compared with? Ganesh Benzoplast ranks 3 of 9 Chemicals - Inorganic companies on the 4-Factor Sector Score, with 57.1 out of 100. 1. [Deepak Nitrite Ltd](https://www.sectoralpha.in/stocks/deepak-nitrite-ltd) DEEPAKNTR · quiet · Most evidence points up · 100% evidence 70.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 32.7/35 · Revenue 23.8% · Profit 100% · Operating margin change 9 points · 100% evidence Capital efficiency 12.4/25 · ROCE 11.4% · Operating margin 20% · 100% evidence Valuation 15.6/20 · P/E 19.4× · PEG 0.89 · 100% evidence Relative strength 9.3/20 · Lead over its industry -6.1% · Lead over NIFTY 500 -1.7% · 1 year -12.1% · 100% evidence · 0 of 12 weeks ahead Exact sum: 32.7 + 12.4 + 15.6 + 9.3 = 70 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [Indo Borax & Chemicals Ltd](https://www.sectoralpha.in/stocks/indo-borax-chemicals-ltd) INDOBORAX · leader · Evidence leans up · 96% evidence 59.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.8/35 · Revenue 28.9% · Profit 47.4% · Operating margin change 5 points · 88% evidence Capital efficiency 18.6/25 · ROCE 15.4% · Operating margin 28% · 100% evidence Valuation 4.4/20 · P/E 25.5× · PEG 1.77 · 100% evidence Relative strength 11.8/20 · Lead over its industry 19.3% · Lead over NIFTY 500 22.2% · 1 year 44% · 100% evidence · 11 of 12 weeks ahead Exact sum: 24.8 + 18.6 + 4.4 + 11.8 = 59.6 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 3. Ganesh Benzoplast Ltd this page GANESHBE · losing its lead · Evidence leans up · 74% evidence 57.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.1/35 · Revenue 13.1% · Profit 87.2% · Operating margin change -7 points · 88% evidence Capital efficiency 11.2/25 · ROCE 14.5% · Operating margin 23% · 100% evidence Valuation 16.1/20 · P/E 9.7× · PEG 0.25 · 65% evidence Relative strength 8.7/20 · Lead over its industry n/a · Lead over NIFTY 500 -3.7% · 1 year 1.9% · 25% evidence · 9 of 12 weeks ahead Exact sum: 21.1 + 11.2 + 16.1 + 8.7 = 57.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [Tanfac Industries Ltd](https://www.sectoralpha.in/stocks/tanfac-industries-ltd) TANFACIND · leader · Evidence leans up · 76% evidence 57.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 12.0/35 · Revenue 13.2% · Profit -29.2% · Operating margin change -1 points · 83% evidence Capital efficiency 16.5/25 · ROCE 23.9% · Operating margin 15% · 95% evidence Valuation 8.5/20 · P/E 112× · PEG n/a · 15% evidence Relative strength 20.0/20 · Lead over its industry 44.2% · Lead over NIFTY 500 48.6% · 1 year 82.1% · 100% evidence · 12 of 12 weeks ahead Exact sum: 12 + 16.5 + 8.5 + 20 = 57 · What this means: Relative strength against the index is 48.6%, and revenue and profit growth are weak. 5. [J.G.Chemicals Ltd](https://www.sectoralpha.in/stocks/jgchemicals-ltd) JGCHEM · leader · Evidence leans up · 63% evidence 56.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.9/35 · Revenue 24% · Profit 16.4% · Operating margin change 2 points · 83% evidence Capital efficiency 15.5/25 · ROCE 17.7% · Operating margin 11% · 76% evidence Valuation 7.5/20 · P/E 29.3× · PEG n/a · 50% evidence Relative strength 12.0/20 · Lead over its industry n/a · Lead over NIFTY 500 33.3% · 1 year 31.2% · 25% evidence · 12 of 12 weeks ahead Exact sum: 21.9 + 15.5 + 7.5 + 12 = 56.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Sree Rayalaseema Hi-Strength Hypo Ltd](https://www.sectoralpha.in/stocks/sree-rayalaseema-hi-strength-hypo-ltd) SRHHYPOLTD · breaking out · Evidence leans up · 81% evidence 52.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 15.5/35 · Revenue 7.6% · Profit 1.1% · Operating margin change -1 points · 88% evidence Capital efficiency 12.9/25 · ROCE 13.7% · Operating margin 14% · 100% evidence Valuation 12.9/20 · P/E 8.4× · PEG 1.29 · 100% evidence Relative strength 10.7/20 · Lead over its industry n/a · Lead over NIFTY 500 2.9% · 1 year -12.1% · 25% evidence · 8 of 12 weeks ahead Exact sum: 15.5 + 12.9 + 12.9 + 10.7 = 52 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [POCL Enterprises Ltd](https://www.sectoralpha.in/stocks/pocl-enterprises-ltd) POEL · Evidence leans down · 69% evidence 46.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 7.8/43.75 · Revenue 4.6% · Profit -2% · Operating margin change -3 points · 88% evidence Capital efficiency 19.8/31.25 · ROCE 26.6% · Operating margin 2.5% · 100% evidence Valuation 18.4/25 · P/E 12.2× · PEG 0.71 · 65% evidence Relative strength: no reading this week · its 20 points are shared across the other three Exact sum: 7.8 + 19.8 + 18.4 = 46 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: There is no relative-strength reading for this week, so the score is built from earnings, capital efficiency and valuation alone. 8. [Archean Chemical Industries Ltd](https://www.sectoralpha.in/stocks/archean-chemical-industries-ltd) ACI · quiet · Most evidence points down · 90% evidence 29.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 6.9/35 · Revenue 6% · Profit -43.3% · Operating margin change -3 points · 100% evidence Capital efficiency 9.6/25 · ROCE 7.4% · Operating margin 24% · 100% evidence Valuation 8.5/20 · P/E 54.7× · PEG n/a · 50% evidence Relative strength 4.8/20 · Lead over its industry -18.3% · Lead over NIFTY 500 -14% · 1 year -33.1% · 100% evidence · 0 of 12 weeks ahead Exact sum: 6.9 + 9.6 + 8.5 + 4.8 = 29.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Fischer Medical Ventures Ltd](https://www.sectoralpha.in/stocks/fischer-medical-ventures-ltd) FISCHER · quiet · Most evidence points down · 71% evidence 26.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 14.2/35 · Revenue 39.1% · Profit -80% · Operating margin change -269.5 points · 65% evidence Capital efficiency 1.8/25 · ROCE -1.6% · Operating margin -261.1% · 100% evidence Valuation 8.9/20 · P/E 58.4× · PEG n/a · 15% evidence Relative strength 1.7/20 · Lead over its industry -36.8% · Lead over NIFTY 500 -33.5% · 1 year -79% · 100% evidence · 2 of 12 weeks ahead Exact sum: 14.2 + 1.8 + 8.9 + 1.7 = 26.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Chemicals - Inorganic](https://www.sectoralpha.in/sectors/chemicals-inorganic), all 9 compared on one page. ## Which companies are close to Ganesh Benzoplast in size? Ganesh Benzoplast is the 8th largest of 9 Chemicals - Inorganic companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Archean Chemical Industries, J.G.Chemicals, Fischer Medical Ventures, Indo Borax & Chemicals and Sree Rayalaseema Hi-Strength Hypo. Just below it: POCL Enterprises. ### Chemicals - Inorganic companies close in size

1. [Archean Chemical Industries Ltd](https://www.sectoralpha.in/stocks/archean-chemical-industries-ltd) ₹5,460 crore
2. [J.G.Chemicals Ltd](https://www.sectoralpha.in/stocks/jgchemicals-ltd) ₹2,204 crore
3. [Fischer Medical Ventures Ltd](https://www.sectoralpha.in/stocks/fischer-medical-ventures-ltd) ₹1,732 crore
4. [Indo Borax & Chemicals Ltd](https://www.sectoralpha.in/stocks/indo-borax-chemicals-ltd) ₹1,248 crore
5. [Sree Rayalaseema Hi-Strength Hypo Ltd](https://www.sectoralpha.in/stocks/sree-rayalaseema-hi-strength-hypo-ltd) ₹833 crore
6. Ganesh Benzoplast Ltd ₹634 crore
7. [POCL Enterprises Ltd](https://www.sectoralpha.in/stocks/pocl-enterprises-ltd) ₹447 crore

[All 9 Chemicals - Inorganic companies, largest first](https://www.sectoralpha.in/sectors/chemicals-inorganic#all-companies)

### Companies close in size in other industries

1. [Rajapalayam Mills Ltd](https://www.sectoralpha.in/stocks/rajapalayam-mills-ltd) ₹635 crore · Textiles - Spinning
2. [DMCC Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/dmcc-speciality-chemicals-ltd) ₹634 crore · Speciality Chemicals
3. Ganesh Benzoplast Ltd ₹634 crore
4. [Cheviot Company Ltd](https://www.sectoralpha.in/stocks/cheviot-company-ltd) ₹628 crore · Textiles - Jute/Jute Products
5. [Scoda Tubes Ltd](https://www.sectoralpha.in/stocks/scoda-tubes-ltd) ₹628 crore · Steel - Tubes/Pipes

## What else do people ask about Ganesh Benzoplast? ### What is Ganesh Benzoplast's share price today? Ganesh Benzoplast Ltd's share price is ₹94.80, +9.7% over the past year. The whole company is worth ₹682 Cr on the market. In the last 52 weeks it traded between ₹70 to ₹138; today it is 36% of the way up from the low, 9.0% below its 200-day average (as of 3 November 2026). ### What were Ganesh Benzoplast's latest quarterly results? Ganesh Benzoplast Ltd reported revenue of ₹118 Cr and net profit of ₹18.0 Cr for the Jun 2026 quarter. Revenue rose 22.9% and profit rose 0.0% compared with a year earlier. Earnings per share were ₹2.44. The operating margin was 23.0%, 7.0 percentage points lower than a year earlier (as of 3 November 2026). ### What is Ganesh Benzoplast's market cap? Ganesh Benzoplast Ltd's market capitalisation is ₹682 Cr at a share price of ₹94.80. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Ganesh Benzoplast performing? Ganesh Benzoplast Ltd's share price has been rising for 23 weeks. In its latest quarter, revenue rose 22.9% and profit rose 0.0% compared with a year earlier. Over the past 13 weeks it has done worse than the NIFTY 500, for 4 weeks running (as of 3 November 2026). ### Will Ganesh Benzoplast's share price go up? This page does not forecast Ganesh Benzoplast Ltd's share price. What it shows instead: the share price is ₹94.80, and it has been rising for 23 weeks. Its P/E of 10.4× is higher than 42% of its own last 7 years (as of 3 November 2026). ### Who owns Ganesh Benzoplast? Promoters own 39.0% of Ganesh Benzoplast Ltd, foreign institutions 0.5%, domestic institutions 1.6% and the public 58.9% (latest quarter). The biggest change over the last two years: Foreign institutions cut their stake by 4.6 percentage points over 8 quarters (as of 3 November 2026). ### Does Ganesh Benzoplast have too much debt? No, Ganesh Benzoplast Ltd has little debt: its debt is 0.12× its equity, and its operating profit is 16 times its interest bill. FY26 borrowings were ₹76.0 Cr against equity of ₹611 Cr. So the returns on this page come from the business, not borrowed money (as of 3 November 2026). ### Where is Ganesh Benzoplast in its business cycle? Ganesh Benzoplast Ltd's FY26 operating margin was 23.0%, against a 13-year range of 17.0% to 32.0%: the middle of its own range, neither a peak nor a low. The latest quarter was 23.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Ganesh Benzoplast story? The main question: yearly earnings per share moved +94.0% while the share price moved +9.7%. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Ganesh Benzoplast a stock worth studying right now? What the numbers show: Ganesh Benzoplast Ltd's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: whether the price catches up with earnings that have already grown. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ### Is there a Ganesh Benzoplast share price forecast for 2026? What management itself guided: Total LST and rail consideration ₹1,154 crore: approximately ₹500 crore by January 2027, ₹300 crore before March 2027, and ₹354 crore over the following 12-18 months. ## Lists

- Penny stocks: https://www.sectoralpha.in/penny-stocks-india

This is research, not advice. We’re not SEBI-registered.